How Sugar Bonds Shape Flavonoid Power in Food and Health

Flavonoid C-glycosides occupy a curious corner of food chemistry: they are abundant in some of the world’s most familiar plant foods, yet for decades they were treated as the quieter cousins of the better-known O-glycosides. A new review in npj Science of Food brings this class of molecules back into focus, arguing that the way a sugar is attached to a flavonoid backbone—carbon to carbon rather than carbon to oxygen—is not a minor structural footnote but the single most important determinant of how these compounds behave in the food matrix, in the human gut, and in the cell.

Flavonoids themselves are a vast family of plant secondary metabolites built on a fifteen-carbon skeleton of two aromatic rings joined by a three-carbon bridge. Depending on the oxidation state of that central ring, they divide into familiar subclasses such as flavones, flavonols, flavanones, and anthocyanidins. Plants rarely leave these backbones bare; they decorate them with hydroxyl, methyl, and sugar groups, and those decorations govern nearly everything: solubility, stability, color, taste, and biological activity. Glycosylation is the most common decoration of all, and the position and nature of the sugar attachment turns out to matter enormously.

The distinction between O- and C-glycosides is chemical but consequential. In O-glycosides, the sugar hangs from the flavonoid through an oxygen atom, forming a bond that human and microbial enzymes in the small intestine can hydrolyze readily. That cleavage releases the aglycone—the bare flavonoid—which can then be absorbed. C-glycosides, by contrast, form a direct carbon–carbon bond between the sugar and the flavonoid skeleton, typically at the C-6 or C-8 position of the A-ring. That bond is dramatically more stable: it resists acidic conditions in the stomach, resists the human enzymes that strip sugars from O-glycosides, and survives much of the journey through the digestive tract intact.

For years, this resilience was interpreted as bad news for bioavailability. If a compound cannot be de-glycosylated, the reasoning went, it cannot release its active aglycone, and so C-glycosides such as vitexin, isovitexin, orientin, homoorientin, and the iconic apigenin derivatives of chamomile and buckwheat must be poorly absorbed and therefore biologically inert. Recent work has complicated that picture. Studies with isolated human gut microbiota and animal models show that colonic bacteria, particularly certain Bacteroides and Eubacterium strains, possess C-glycoside-cleaving enzymes capable of breaking the resistant bond slowly, releasing aglycones and a cascade of smaller phenolic metabolites deeper in the intestine, where they can act locally on the gut lining and enter the portal circulation.

The review’s treatment of structure–activity relationships builds on this metabolic nuance. Biological activity in flavonoids correlates with recognizable structural features: the catechol group on the B-ring drives antioxidant and metal-chelating activity, a planar chromone core supports enzyme binding, and specific hydroxylation patterns govern interactions with signaling proteins. Glycosylation at the A-ring modifies these effects indirectly but measurably, altering solubility, membrane affinity, and the compound’s ability to reach intracellular targets. C-glycosylation, by locking the sugar permanently onto the skeleton, produces molecules whose activity profiles differ from those of their O-glycosylated counterparts—not better or worse in absolute terms, but differently distributed between the gut lumen, the bloodstream, and the target tissues.

Where C-glycosides shine is in stability, and stability is the currency of food formulation. O-glycosides and free aglycones are notoriously fragile: they degrade under heat, oxidize in the presence of oxygen and light, and lose activity during pasteurization, baking, and storage. C-glycosides, anchored by their carbon–carbon bond, tolerate far harsher processing. Vitexin and isovitexin in mung bean and buckwheat survive boiling and extrusion with comparatively modest losses. Orientin and its isomers in millet and bamboo leaves persist through drying and fermentation. For food manufacturers seeking to add functional ingredients without sacrificing shelf life, this processing robustness is a genuine advantage over more celebrated but more delicate polyphenols.

The food sources of these compounds are worth cataloguing because many are staples rather than supplements. Buckwheat is arguably the flagship: its groats and hulls are rich in vitexin and isovitexin derivatives, and traditional buckwheat products across East Asia and Eastern Europe deliver measurable daily doses. Millets, particularly foxtail and proso varieties, contribute orientin and homoorientin. Mung bean, a protein staple across South and Southeast Asia, is one of the densest vitexin sources in any human diet. Date palm pollen, swertia herbs, passion fruit by-products, fenugreek, jujube, and several medicinal plants used in traditional teas round out the list. Because these sources are often underutilized crops or agricultural by-products, the review positions C-glycosides as an opportunity to extract added value from material streams that today carry little market premium.

Analysis techniques for these molecules have matured considerably. Because C-glycosides resist the acid hydrolysis that food chemists traditionally used to quantify flavonoid content, older analytical protocols systematically underestimated them. Modern high-resolution liquid chromatography–mass spectrometry, with fragmentation patterns that distinguish 6-C from 8-C isomers, has revealed that many plant foods carry substantially more C-glycoside content than previously recognized. Nuclear magnetic resonance remains the definitive tool for assigning the exact carbon–carbon linkage position, but diagnostic mass-spectrometric signatures now allow rapid screening of breeding lines and processed products, opening the door to quality control and authenticity testing for functional foods built around these compounds.

On the application side, the review identifies several converging opportunities. In functional beverages, the stability of C-glycosides against pasteurization makes them plausible candidates for standardized polyphenol fortification. In bakery and extruded snack products, their thermal tolerance means they survive the processing that destroys anthocyanins and most aglycones. In encapsulation and delivery systems, their solubility and resistance to gastric degradation make them well suited to colon-targeted release strategies, where bacterial C-glycosidase activity provides a built-in triggering mechanism. And in the growing market for plant-based proteins, crops such as buckwheat and mung bean carry their flavonoid payload alongside the protein, offering clean-label fortification without added extracts.

The health claims remain, appropriately, cautious. Evidence from cell culture and animal studies points to anti-inflammatory, antioxidant, antidiabetic, and neuroprotective effects for specific C-glycosides, with vitexin and orientin among the most studied. But human intervention trials are scarce, and the review is explicit that translating structure–activity relationships from laboratory models to dietary benefit requires dosing studies, metabolite identification in human subjects, and a better understanding of inter-individual variation in gut microbiota composition. What the review does establish is the framework: because the C-glycosidic bond dictates where and when these compounds are activated, structure determines not just potency but delivery, and any future clinical work must account for that metabolic choreography.

The larger significance of the review may lie in how it reframes an old debate. For decades, bioavailability was treated as a gatekeeper metric: compounds that were poorly absorbed were dismissed. But the gut microbiota era has changed the question. A compound that survives intact until the colon and is then transformed into active metabolites by resident bacteria is not poorly bioavailable—it is precisely targeted. Flavonoid C-glycosides, with their indigestible sugar bond and their abundance in underexploited staple crops, may be one of the clearest examples of this shift in thinking, and the food industry’s ability to harness them will depend on marrying the structure–activity knowledge summarized in this review with the practical realities of processing, formulation, and clinical validation.

Subject of Research: Structure–activity relationships of flavonoid C-glycosides and their applications in food science and nutrition

Article Title: Flavonoid C-glycosides: from structure-activity relationships to food applications

Article References: Wu, Z., Shi, D., Wang, Y., & Zeng, S. (2026). Flavonoid C-glycosides: from structure-activity relationships to food applications. npj Science of Food. https://doi.org/10.1038/s41538-026-01141-7

Image Credits: AI Generated

DOI: 10.1038/s41538-026-01141-7

Keywords: flavonoid C-glycosides, structure-activity relationships, vitexin, orientin, buckwheat, gut microbiota, bioavailability, functional foods, food chemistry, polyphenols, mung bean, food processing